AIRVO与人工鼻在高位截瘫气管切开造口患者中应用效果比较

Effect of AIRVO and Artificial Nose in High Paraplegia Patients with Tracheotomy

摘要: 目的：比较AIRVO (高流量湿化治疗仪)与人工鼻(一次性湿热交换器)在ICU高位截瘫气管切开患者撤离呼吸机后气道管理中的临床应用效果。方法：回顾分析了2016年1月至2017年6月，我院ICU在引进AIRVO前后，53例因高位截瘫行气管切开造口患者在撤离呼吸机后的气道湿化方法，其中2016年1月~9月的27例为人工鼻湿化组，2016年10月~2017年6月的26例为AIRVO湿化组，比较两组患者撤离呼吸机后48h气道湿化效果、氧疗效果与肺部感染发生率。结果：AIRVO组的湿化与氧疗效果均优于人工鼻组，肺部感染发生率低于人工鼻组，差异有统计学意义(P < 0.05)。结论：撤离呼吸机后的ICU气管切开造口患者应用AIRVO可明显提高气道湿化、氧疗效果、降低肺部感染率、具备兼容性好和精确调控输入量等优点，值得临床推广使用。

Abstract: Objective: To compare the application effect of AIRVO (High flow humidification Therapeutic in-strument) and artificial nose (Disposable damp heat exchanger) in airway management of high paraplegia patients with tracheotomy after ventilator withdrawal in ICU. Methods: 53 high parap-legia patients who were evacuated from ventilator after tracheotomy in our ICU from January 2016 to June 2017 were selected as study objects. A retrospective analysis of 27 patients with high paraplegia admitted from January 2016 to September 2016 after evacuation of the ventilator was performed using artificial nasal airway humidification as the control group. From October 2016 to June 2017, 26 patients with high paraplegia who were evacuated from the ventilator used AIRVO for airway humidification as observation group. On the basis of conventional treatment, the humi-dification effect, oxygen therapeutic effect and pulmonary infection rate of the two groups were compared after evacuation of the ventilator 48 h. Results: The effect of humidification and oxygen therapy in the study group was better than that in the control group, and the incidence of pulmo-nary infection was lower than that in the control group (P < 0.05). Conclusion: The application of AIRVO in ICU patients with tracheotomy after evacuation of ventilator can significantly improve airway humidification, oxygen therapy effect and reduce pulmonary infection rate. In addition, AIRVO has the advantages of good compatibility and precise control of input, which is worthy of clinical promotion.